Literature DB >> 26765463

Is Brown Adipose Tissue Visualization Reliable on 99mTc-Methoxyisobutylisonitrile Diagnostic SPECT Scintigraphy?

Mahdi Haghighatafshar1, Farinaz Farhoudi.   

Abstract

The 99mTc-MIBI has been used with great value as a diagnostic technique in patients with primary hyperparathyroidism. False-positive scans may occur due to misinterpretation of the physiologic distribution of the 99mTc-MIBI. Reviewing consecutive SPECT scans, we evaluated this possibility and assessed how frequently brown adipose tissue (BAT) is seen on 99mTc-MIBI scintigraphy. Here, we retrospectively reviewed scans of consecutive patients who were evaluated for parathyroid adenomas from March 2015 to June 2015, using dual-phase (early and delayed) planar imaging and SPECT. We identified 60 patients (48 female and 12 male; mean age, 52.25 ± 15.20 years; range, 22-86 years).We detected the presence of 99mTc-MIBI uptake in BAT in 20 of 60 patients (33.33%) in the neck. Although the patients with T99mc-MIBI uptake in BAT were younger (mean age, 48.85 ± 15.27 years, range, 26-73 years) than the patients with no 99mTc-MIBI uptake (mean age, 53.95 ± 15.07 years, range, 22-86 years), this difference was not statistically significant (P = 0.224). The percentage of female patients with BAT detection was higher (17/48 patients; 37.5%) than that of the male population (3/12 patients; 25%), this difference was not also statistically significant (P = 0.85).In patient population referred to 99mTc MIBI scintigraphy of the parathyroid glands, uptake of 99mTc-MIBI in BAT should not be misinterpreted with 99mTc-MIBI-avid-tumors. Fused SPECT/CT images (not SPECT-only) are necessary to distinguish BAT from bone, muscle, thyroid, myocardium, parathyroids, and other structures in the neck and chest.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26765463      PMCID: PMC4718289          DOI: 10.1097/MD.0000000000002498

Source DB:  PubMed          Journal:  Medicine (Baltimore)        ISSN: 0025-7974            Impact factor:   1.817


INTRODUCTION

Thallium-201 (201Tl) scintigraphy was the first radionuclide diagnostic method widely used in the 1980s for hyperfunctioning parathyroid localization.[1] For parathyroid localization 99mTc scintigram which is taken up only by the thyroid was digitally subtracted from the 201Tl scintigram which is taken up by both the thyroid and parathyroid glands.[2] In 1989, Coakley et al[3] used 99mTc-methoxyisobutylisonitrile (99mTc-MIBI) for parathyroid scintigraphy. Thallium superseded by the novel radionuclide because of several advantages such as higher energy (that makes it ideal for gamma camera imaging), better dosimetry and higher sensitivity.[4,5] The subtraction of thyroid images obtained with 123I or 99mTc from those obtained with 99mTc-MIBI is a variation of this method.[6,7] Taillefer et al[8] found that 99mTc-MIBI washes out more rapidly from thyroid gland than from hyperfunctioning parathyroid glands, so they suggested the use of a single-isotope dual-phase (early and delayed) scintigraphic method. 99mTc tetrofosmin also has been used for parathyroid imaging, but the experiential data for this technique are scarce.[1] In some adults, brown adipose tissue (BAT) is metabolically active and can cause false-positive scans due to misinterpretation of the physiologic distribution of the 99mTc MIBI. Previously, BAT has been detected by some nuclear imaging methods such as single-photon imaging using 123I-metaiodobenzylguanidine,[9,10] and by PET using 18F-FDG[11,12] or 99mTc-tetrofosmin[13] in humans. Assessment of the visualized body during a 99mTc MIBI scintigraphy of the heart or parathyroid glands is essential to exclude incidental tumoral uptake, which may be 99mTc-MIBI-avid. As we know, there has been some new evidence of[1,14,15]99mTc-MIBI uptake into BAT in humans so, reviewing consecutive SPECT scans we evaluated this possibility and assessed how frequently BAT is seen on 99mTc-MIBI scintigraphy.

MATERIALS AND METHODS

Patient Population

Here we retrospectively reviewed scans of consecutive patients who were evaluated for parathyroid adenomas from March 2015 to June 2015, using dual-phase (early and delayed) planar imaging and SPECT. We identified 60 patients (48 female and 12 male; mean age, 52.25 ± 15.20 years, range, 22–86 years). As the study was retrospective and also anonymous, ethical approval was not necessary.

Imaging Protocol and Analysis

All patients were injected intravenously with 740 to 925 MBq of 99mTc-MIBI. We used a commercially available sestamibi kit (AEOI, Tehran, Iran) and according to the manufacturer's instructions, it was labeled and quality controlled.

Imaging

At 20, 120, and 180 min after injection, 10-min anterior planar images were acquired in a 128 × 128 matrix, with a 20% window centered around the 140-keV photopeak, using a low-energy, high-resolution parallel collimator. SPECT images of the neck and chest were obtained using a rotating, calibrated General Electric Infinia Hawkeye 4 scintillation dual-head gamma camera(Fairfield , Connecticut, United States) equipped with a low energy high resolution parallel hole collimator immediately after planar imaging (at approximately 20 min).

RESULTS

We detected the presence of 99mTc-MIBI uptake in BAT in 20 of 60 patients (33.33%) in the neck (Figures 1 and 2). When BAT was visualized, it was detected on both early and delayed scans. Although the patients with 99mTc-MIBI uptake in BAT were younger (mean age, 48.85 ± 15.27 years, range, 26–73 years) than the patients with no 99mTc-MIBI uptake (mean age, 53.95 ± 15.07 years, range, 22–86 years), this difference was not statistically significant (P = 0.224). The percentage of female patients with BAT detection was higher (17/48 patients; 37.5%) than that of the male population (3/12 patients; 25%), this difference was not also statistically significant (P = 0.85).
FIGURE 1

Early coronal slices of SPECT (A) and maximum-intensity projection (B) of a patient with primary hyperparathyroidism.99mTc-MIBI-avid BAT is seen in the neck. 99mTc-MIBI = 99mTc-methoxyisobutylisonitrile.

FIGURE 2

Scans performed on a 1-y-old infant with primary hyperparathyroidism with supraclavicular BAT (not included in data analysis).

Early coronal slices of SPECT (A) and maximum-intensity projection (B) of a patient with primary hyperparathyroidism.99mTc-MIBI-avid BAT is seen in the neck. 99mTc-MIBI = 99mTc-methoxyisobutylisonitrile. Scans performed on a 1-y-old infant with primary hyperparathyroidism with supraclavicular BAT (not included in data analysis).

DISCUSSION

After intravenous injection of 99mTc-MIBI, this cationic radiotracer, which is also lipophilic, is distributed by blood flow in the body, cross the cellular membrane by passive transport, and become concentrated in the mitochondria.[16] As hyperplastic parathyroid glands and parathyroid adenomas contain oxyphil cells laden with mitochondria, they can be visualized in 99mTc-MIBI scintigraphy.[1] Concentration of radiotracer is generally noticed in the infusion administered vein and it should not be mistaken with abnormal findings.[1] Pioneer 99mTc-MIBI usage as a radiotracer was limited to myocardial scintigraphy but became expanded due to considerable concentration in different type of tumors. Although normal parathyroid glands have no uptake, normal concentration of 99mTc-MIBI is visualized in many tissues such as the thyroid gland, parotid and submandibular salivary glands, heart, and liver. Occasionally mild generalized uptake in the bone marrow and thymic uptake in young patients is visualized. Secondary to radiotracer secretion from the salivary glands, consideration of oral cavity accumulation in nonsevere degree is probable.[1]99mTc-MIBI uptake also may be seen in BAT, metabolically active tissue, and should not be misinterpreted with disease, such as abnormal uptake in tumors, thyroid cancer, lymph nodes, parathyroid adenomas, or muscle.[17] Despite reports of 99mTc-MIBI uptake in BAT in rats,[18,19] only a few data exist in the literature demonstrating 99mTc-MIBI uptake in BAT in a human, using SPECT (or SPECT/CT).[14,15] BAT is depicted by abundant vasculature and high mitochondrial metabolic activity and plays an important role in thermoregulation. Although additional studies are needed to understand the precise mechanism of 99mTc-MIBI uptake in BAT but it is likely related to relatively high regional blood flow, possibly even more than to increased mitochondrial density and function.[14,18-20] The frequency of BAT visualization in our study (SPECT-only) is very high in comparison with the frequency reported in studies with SPECT-CT in adults (33.33% for SPECT vs 6.3% for SPECT-CT). A higher frequency of BAT visualization with SPECT in this study might be related to the fact that no CT was obtained to ascertain that the tracer accumulation definitely is in BAT. In accordance with previous study[21] that showed the importance of fused single-photon emission computed tomography (SPECT)/computed tomography (CT) images in radionuclide scintigraphy, BAT also could be clearly distinguished from bone, muscle, myocardium, thyroid, parathyroids, and other structures in the neck and chest (CT image of the expected region had to show fat tissue density and SPECT-only images of the patients had to show BAT in the same region).

CONCLUSION

In patient population referred to 99mTc MIBI scintigraphy of the parathyroid glands, uptake of 99mTc-MIBI in BAT should not be misinterpreted with 99mTc-MIBI-avid-tumors. Fused SPECT/CT images (not SPECT-only) are necessary to distinguish BAT from bone, muscle, thyroid, myocardium, parathyroids, and other structures in the neck and chest.
  20 in total

1.  Uptake in supraclavicular area fat ("USA-Fat"): description on 18F-FDG PET/CT.

Authors:  Christian Cohade; Medhat Osman; Harpreet K Pannu; Richard L Wahl
Journal:  J Nucl Med       Date:  2003-02       Impact factor: 10.057

2.  Detection of 99mTc-sestamibi uptake in brown adipose tissue with SPECT-CT.

Authors:  Tarik Belhocine; Anil Shastry; Albert Driedger; Jean-Luc Urbain
Journal:  Eur J Nucl Med Mol Imaging       Date:  2006-09-26       Impact factor: 9.236

3.  New perspectives in localizing enlarged parathyroids by technetium-thallium subtraction scan.

Authors:  G Ferlin; N Borsato; M Camerani; N Conte; D Zotti
Journal:  J Nucl Med       Date:  1983-05       Impact factor: 10.057

4.  Comparative evaluation of the diagnostic accuracy of (99m)Tc-sestamibi gated SPECT using five different sets of image acquisitions at stress and rest phases for the diagnosis of coronary artery disease.

Authors:  Babak Fallahi; Mahdi Haghighatafshar; Farinaz Farhoudi; Yalda Salehi; Farahnaz Aghahosseini
Journal:  Am J Nucl Med Mol Imaging       Date:  2013-12-15

5.  Radionuclide imaging metabolic activity of brown adipose tissue in a patient with pheochromocytoma.

Authors:  K Fukuchi; M Tatsumi; Y Ishida; N Oku; J Hatazawa; R L Wahl
Journal:  Exp Clin Endocrinol Diabetes       Date:  2004-11       Impact factor: 2.949

6.  Prospective comparison of technetium-99m-sestamibi/iodine-123 radionuclide scan versus high-resolution ultrasonography for the preoperative localization of abnormal parathyroid glands in patients with previously unoperated primary hyperparathyroidism.

Authors:  A T Casas; G J Burke; A R Mansberger; J P Wei
Journal:  Am J Surg       Date:  1993-10       Impact factor: 2.565

7.  Value of technetium 99m sestamibi iodine 123 imaging in reoperative parathyroid surgery.

Authors:  C J Weber; J Vansant; N Alazraki; J Christy; N Watts; L S Phillips; K Mansour; W Sewell; W C McGarity
Journal:  Surgery       Date:  1993-12       Impact factor: 3.982

Review 8.  Parathyroid scintigraphy in patients with primary hyperparathyroidism: 99mTc sestamibi SPECT and SPECT/CT.

Authors:  Hedieh K Eslamy; Harvey A Ziessman
Journal:  Radiographics       Date:  2008 Sep-Oct       Impact factor: 5.333

9.  Visualization of interscapular brown adipose tissue using (99m)Tc-tetrofosmin in pediatric patients.

Authors:  Kazuki Fukuchi; Yasuo Ono; Yayoi Nakahata; Yoko Okada; Kohei Hayashida; Yoshio Ishida
Journal:  J Nucl Med       Date:  2003-10       Impact factor: 10.057

10.  Assessment of brown adipose tissue activity in rats by 99mTc-sestamibi uptake.

Authors:  D Kyparos; G Arsos; S Georga; A Petridou; A Kyparos; E Papageorgiou; V Mougios; C Matziari; C Karakatsanis
Journal:  Physiol Res       Date:  2006       Impact factor: 1.881

View more
  2 in total

Review 1.  Non-invasive methods for the assessment of brown adipose tissue in humans.

Authors:  Maria Chondronikola; Scott C Beeman; Richard L Wahl
Journal:  J Physiol       Date:  2018-01-15       Impact factor: 5.182

2.  Effects of the attenuation correction and reconstruction method parameters on conventional cardiac dynamic SPECT.

Authors:  Mohammadreza Mohseni; Reza Faghihi; Mahdi Haghighatafshar; Seyed Mohammad Entezarmahdi
Journal:  Medicine (Baltimore)       Date:  2018-09       Impact factor: 1.889

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.